Understanding Swiss Drug Policy Change and the Introduction of Heroin Maintenance Treatment
Author(s) -
Riaz Khan,
Yasser Khazaal,
Gabriel Thorens,
Daniele Zullino,
Ambros Uchtenhagen
Publication year - 2014
Publication title -
european addiction research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.862
H-Index - 54
eISSN - 1421-9891
pISSN - 1022-6877
DOI - 10.1159/000357234
Subject(s) - heroin , stakeholder , politics , political science , medical prescription , addiction , feeling , public administration , democracy , element (criminal law) , legislation , public relations , drug , medicine , pharmacology , psychology , psychiatry , law , social psychology
The aim of this paper is to illustrate how Switzerland was able to play such a pioneering role in the field of addiction treatment, in creating a drug policy that includes the medical prescription of diacetylmorphine (heroin). The paper will also describe the role of knowledge brokering processes and coalition building in the different phases of the development of the Swiss drug policy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom